USP25 promotes ferroptosis in diabetic retinopathy by deubiquitinating p53 and suppressing the GPX4/SLC7A11 axis
- 1Department of Ophthalmology The Second Hospital of Hebei Medical University Shijiazhuang China
- 2Department of Hemodialysis The Second Hospital of Hebei Medical University Shijiazhuang China
Abstract
Objective: To explore the expression of the deubiquitinase (DUB) USP25 in diabetic retinopathy (DR) and its mechanistic role in regulating ferroptosis.
Methods: Bioinformatics was used to screen for DR‐related DUB candidate genes. USP25 expression was validated in a streptozotocin‐induced diabetic mouse model and high glucose (HG)‐treated ARPE‐19 cells. Loss‐ and gain‐of‐function approaches for USP25 were employed to assess retinal structural damage, tight junction proteins, cell viability, and TUNEL positivity. Ferroptosis‐related changes were evaluated by measuring iron content, Fe2+ fluorescent signals, lipid peroxidation levels, and antioxidant enzyme activities. The molecular mechanism underlying USP25‐mediated ferroptosis was elucidated through bioinformatics prediction, co‐immunoprecipitation, and protein stability assays, followed by rescue experiments with p53 knockdown.
Results: USP25 was upregulated in the retinas of diabetic mice. USP25 knockdown ameliorated retinal structural damage and restored the expression of tight junction proteins (ZO‐1 and occludin) in DR mice. USP25 exacerbated HG‐induced cellular injury and ferroptosis by promoting iron accumulation, enhancing lipid peroxidation, suppressing the antioxidant defense system, and downregulating the ferroptosis suppressors GPX4 and SLC7A11. Mechanistically, USP25 stabilized p53 protein by reducing its ubiquitination. Rescue experiments further demonstrated that p53 knockdown significantly reversed ferroptosis‐related alterations in the context of USP25 overexpression, mitigating ferroptosis‐related damage in ARPE‐19 cells and retinal tissues of diabetic mice.
Conclusion: USP25 is aberrantly upregulated in DR and promotes ferroptosis by deubiquitinating and stabilizing p53, thereby exacerbating retinal damage. The USP25–p53–ferroptosis axis may represent a potential therapeutic target for DR intervention.
Related
- SGLT2 inhibitors attenuate diabetic kidney disease by suppressing YAP dependent ferroptosis
- CDCA5 promotes hepatocellular carcinoma progression by suppressing ferroptosis through PP2Ac/p53/STEAP3 signaling
- Targeting Caveolin-1 Alleviated Diabetic Retinopathy Injury through Protecting Müller Cells from Ferroptosis via the xCT/GPX4 Signaling Pathway
- ATF3 Promotes Solasonine-Triggered Ferroptosis in Glioma Cells by Suppressing Glycolysis.
- 4-Methoxydalbergione triggers ferroptosis in bladder cancer by suppressing the AKT/mTOR/GPX4 axis
BibTeX
@article{gao2026usp25,
title = {{USP25 promotes ferroptosis in diabetic retinopathy by deubiquitinating p53 and suppressing the GPX4/SLC7A11 axis}},
author = {Yanjun Gao and Wenjing Zhao and Qiannan Chai and Cunxi Ye},
journal = {Journal of Diabetes Investigation},
year = {2026},
month = oct,
doi = {10.1111/jdi.70467},
url = {https://doi.org/10.1111/jdi.70467},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - USP25 promotes ferroptosis in diabetic retinopathy by deubiquitinating p53 and suppressing the GPX4/SLC7A11 axis
AU - Yanjun Gao
AU - Wenjing Zhao
AU - Qiannan Chai
AU - Cunxi Ye
PY - 2026
DA - 2026/10/27
JO - Journal of Diabetes Investigation
DO - 10.1111/jdi.70467
UR - https://doi.org/10.1111/jdi.70467
AB - Objective: To explore the expression of the deubiquitinase (DUB) USP25 in diabetic retinopathy (DR) and its mechanistic role in regulating ferroptosis. Methods: Bioinformatics was used to screen for DR‐related DUB candidate genes. USP25 expression was validated in a streptozotocin‐induced diabetic mouse model and high glucose (HG)‐treated ARPE‐19 cells. Loss‐ and gain‐of‐function approaches for USP25 were employed to assess retinal structural damage, tight junction proteins, cell viability, and TUNEL positivity. Ferroptosis‐related changes were evaluated by measuring iron content, Fe2+ fluorescent signals, lipid peroxidation levels, and antioxidant enzyme activities. The molecular mechanism underlying USP25‐mediated ferroptosis was elucidated through bioinformatics prediction, co‐immunoprecipitation, and protein stability assays, followed by rescue experiments with p53 knockdown. Results: USP25 was upregulated in the retinas of diabetic mice. USP25 knockdown ameliorated retinal structural damage and restored the expression of tight junction proteins (ZO‐1 and occludin) in DR mice. USP25 exacerbated HG‐induced cellular injury and ferroptosis by promoting iron accumulation, enhancing lipid peroxidation, suppressing the antioxidant defense system, and downregulating the ferroptosis suppressors GPX4 and SLC7A11. Mechanistically, USP25 stabilized p53 protein by reducing its ubiquitination. Rescue experiments further demonstrated that p53 knockdown significantly reversed ferroptosis‐related alterations in the context of USP25 overexpression, mitigating ferroptosis‐related damage in ARPE‐19 cells and retinal tissues of diabetic mice. Conclusion: USP25 is aberrantly upregulated in DR and promotes ferroptosis by deubiquitinating and stabilizing p53, thereby exacerbating retinal damage. The USP25–p53–ferroptosis axis may represent a potential therapeutic target for DR intervention.
SN - 2040-1116
SN - 2040-1124
ER -